ARTHROPLASTY
Topical tranexamic acid and betadine combination effective for reducing blood loss in TKA
This report has been verified
by one or more authors of the
original publication.
Orthop Traumatol Surg Res. 2015 Feb;101(1):83-7.
125 patients undergoing total knee arthroplasty were randomized to receive either 1.5g or 3g of topical tranexamic acid (TXA) in 100mL of povidone-iodine solution, or simply the povidone-iodine solution alone into the knee before wound closure. The purpose of this study was to examine the effect of this combination of topical applications on blood loss and infection rate. Secondarily, hemoglobin, hematocrit, platelet count, and coagulation parameters were compared. The results indicated that patients receiving tranexamic acid displayed higher hemoglobin levels, and less blood loss, with no difference in complication rates, when compared to the control group.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
